Trial Information

Summary: Post Heart Attack Ventricular Remodeling Study CSPP100A2340

Novartis is conducting this clinical research study is to determine if combining standard medical therapies with an investigational drug is safe and effective for participants who are 18 years of age and older and suffered a heart attack which may have caused a decrease in their heart's ability to pump blood. An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

Participants will be required to take 3 tablets a day and visit the study center 10 times over 38 weeks.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: December 3, 2008 at 3:34:04 PM